Prof Silvia Marino
Professor of Neuropathology
Blizzard Institute - Centre for Genomics for Child Health
Queen Mary University of London
Queen Mary University of London
Research
Brain Cancer, Epigenetics, 3D models, organoids
Interests
We have established cerebral organoid models derived from expanded potential stem cells (EPSCs) and developed robust protocols to achieve region specific differentiation, including forebrain, cerebellum, and midbrain/pons identities. These models have been extensively characterised using single cell transcriptomic profiling and bulk epigenetic analyses. By leveraging similarly well annotated collections of human brain tissue, we have been able to accurately stage our organoids developmentally and assess the fidelity with which they recapitulate key features of the human brain.We have further demonstrated that progenitor populations within these organoids can be genetically engineered to initiate tumourigenesis, and that primary human brain tumour cells can be co cultured with organoids to model tumour growth within a relevant microenvironmental niche. Building on this foundation, we are now interested in exploring how these organoid platforms could be further developed and scaled to enable high throughput CRISPR based genetic screens and compound screening approaches.
Publications of specific relevance to Predictive in vitro Models
2025
MDB-13. Modelling medulloblastoma pathogenesis and treatment in human cerebellar organoidsWillott T, Nicholson JG, Xiao Y, Ogunbiyi O, Mistry T, Zabet NR, Merve A, Badodi S et al.
Neuro-Oncology Pediatrics, Oxford University Press (Oup) vol. 1 (Supplement_1)
01-08-2025
Disruption of DNA methylation underpins the neuroinflammation induced by targeted CNS radiotherapyMillner TO, Panday P, Xiao Y, Nicholson JG, Boot JR, Arpe Z, Stevens PA, Rahman NN et al.
Brain, Oxford University Press (Oup) vol. 148 (9), 3137-3152.
29-04-2025
A novel model of glioblastoma recurrence to identify therapeutic vulnerabilitiesLucchini S, Nicholson JG, Zhang X, Househam J, Lim YM, Mossner M, Millner TO, Brandner S et al.
Embo Molecular Medicine, Springer Nature vol. 17 (6), 1325-1354.
28-04-2025
Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targetsVinel C, Boot J, Jin W, Pomella N, Hadaway A, Mein C, Zabet NR, Marino S
Bmc Biology, Springer Nature vol. 23 (1)
07-02-2025
2024
Lineage specification in glioblastoma is regulated by METTL7BConstantinou M, Nicholson J, Zhang X, Maniati E, Lucchini S, Rosser G, Vinel C, Wang J et al.
Cell Reports, Elsevier vol. 43 (6)
01-06-2024
2022
Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscapeBoot J, Rosser G, Kancheva D, Vinel C, Lim YM, Pomella N, Zhang X, Guglielmi L et al.
Elife, Elife vol. 11
22-11-2022
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastomaBadodi S, Pomella N, Lim YM, Brandner S, Morrison G, Pollard SM, Zhang X, Zabet NR et al.
Neuro-Oncology, Oxford University Press (Oup) vol. 24 (8), 1273-1285.
25-02-2022
2021
Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastomaVinel C, Rosser G, Guglielmi L, Constantinou M, Pomella N, Zhang X, Boot JR, Jones TA et al.
Nature Communications, Springer Nature vol. 12 (1)
21-10-2021
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptationBadodi S, Pomella N, Zhang X, Rosser G, Whittingham J, Niklison-Chirou MV, Lim YM, Brandner S et al.
Nature Communications, Springer Nature vol. 12 (1)
12-04-2021
Harnessing brain development to understand brain tumoursMarino S, Gilbertson RJ
Development, The Company of Biologists vol. 148 (2)
15-01-2021
2020
Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironmentDumas AA, Pomella N, Rosser G, Guglielmi L, Vinel C, Millner TO, Rees J, Aley N et al.
The Embo Journal, Springer Nature vol. 39 (15)
22-06-2020
Grants
Leveraging the enhancer landscape for precision medicine in glioblastomaNicolae Radu Zabet and Silvia Marino
£501,379 Barts and the London Charity
01-05-2026 - 30-04-2029
Brain Tumour Research CentreSilvia Marino, Sara Badodi, Nicolae Radu Zabet, Lovorka Stojic and Sindhuja Sridharan
£2,709,922 Brain Tumour Research
01-10-2024 - 04-01-2030
Establishment of a Brain Tumour Research Centre of ExcellenceSilvia Marino
£4,753,541 Brain Tumour Research
01-08-2024 - 31-07-2027
Tackling epigenetic deregulation in medulloblastoma and DIPGSilvia Marino
£250,000 Ali's Dream
01-03-2023 - 28-02-2027
Barts Brain Tumour Centre - Basic ScienceSilvia Marino
£1,729,566 Barts and the London Charity
01-01-2019 - 31-10-2026
Characterising the tumour-muscle crosstalk to develop novel treatments for glioblastomaSilvia Marino and Claire Vinel
£225,000 Brain Tumour Charity, The
01-04-2023 - 31-03-2026
On-Demand Targeted RNA Delivery Nanotheranostics for Glioblastoma TreatmentSilvia Marino and Julien Gautrot
£184,106 Barts and the London Charity
01-03-2023 - 01-04-2026
A role of seizures in progression of Glioblastoma multiformeSilvia Marino
£30,000 AMS Academy of Medical Sciences
08-09-2021 - 31-08-2024
Clinical Lecturer Speciality Trainee Placement in Neurosurgery ST4Silvia Marino
£238,025 HEE Health Education England
01-03-2020 - 31-08-2024
Investigating regional heterogeneity and progression-associated markers in oligodendrogliomasThomas Millner and Silvia Marino
£47,146 Pathological Society Of Great Britain And Ireland
01-03-2020 - 01-12-2023
Clinical Lecturer Speciality Trainee Placement in Diagnostic NeuropathologySilvia Marino
£323,097 HEE Health Education England
24-02-2020 - 23-02-2024
A novel epigenetic discovery pipeline for patient-tailored drug monitoring in glioblastomaSilvia Marino and Trevor Graham
£1,476,460 CR-UK Cancer Research UK
01-01-2020 - 10-05-2026
Epigenetic Regulation of Ephrin A5 by BMI1 in human GliomasSilvia Marino
£4,000 Barts and the London Charity
01-02-2018 - 31-01-2019
NIHR IAT - Clinical Research LectureshipsSilvia Marino
£200,000 MCSBHT Medical College of St Bartholomew's Hospital Trust
01-10-2017 - 30-06-2024
A BMI1/CHD7 signature in medulloblastoma with poor prognosisSilvia Marino
£400,933 Medical Research Council
01-12-2015 - 31-01-2019
Phd studentship-Regulation of inflammatory pathways in microglia the innate immune cells of the brainSilvia Marino
£85,656 Willoughby Trustees
01-10-2015 - 31-12-2019
Metabolic analysis of the tumour suppressor protein p73 in medulloblastoma- Paul O'Gorman Post-doctoral Research FellowshipSilvia Marino
£382,077 Children with Cancer UK
01-09-2014 - 29-02-2020


